轩竹生物-B(02575)就建议实施H股全流通向中国证监会备案

Core Viewpoint - The company, Xuan Zhu Biological-B (02575), has submitted a filing application to the China Securities Regulatory Commission (CSRC) for the proposed implementation of full circulation of H-shares, converting a total of 357,245,794 unlisted shares into H-shares on a one-to-one basis [1] Group 1 - The company plans to convert 357,245,794 unlisted shares into H-shares, which will then be listed and traded on the Hong Kong Stock Exchange [1] - The conversion is subject to the completion of all filing requirements, including approval from the CSRC and the Hong Kong Stock Exchange [1] - The company aims to comply with all applicable laws, regulations, and rules during this process [1]